Evgeny Rogaev to Mice, Transgenic
This is a "connection" page, showing publications Evgeny Rogaev has written about Mice, Transgenic.
Connection Strength
0.136
-
Wang X, Campbell B, Bodogai M, McDevitt RA, Patrikeev A, Gusev F, Ragonnaud E, Kumaraswami K, Shirenova S, Vardy K, Alameh MG, Weissman D, Ishikawa-Ankerhold H, Okun E, Rogaev E, Biragyn A. CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis. Brain Behav Immun. 2024 Nov; 122:444-455.
Score: 0.045
-
Ferguson CM, Hildebrand S, Godinho BMDC, Buchwald J, Echeverria D, Coles A, Grigorenko A, Vangjeli L, Sousa J, McHugh N, Hassler M, Santarelli F, Heneka MT, Rogaev E, Khvorova A. Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease. Alzheimers Dement. 2024 04; 20(4):2632-2652.
Score: 0.044
-
Kim K, Wang X, Ragonnaud E, Bodogai M, Illouz T, DeLuca M, McDevitt RA, Gusev F, Okun E, Rogaev E, Biragyn A. Therapeutic B-cell depletion reverses progression of Alzheimer's disease. Nat Commun. 2021 04 12; 12(1):2185.
Score: 0.036
-
Chen F, Wollmer MA, Hoerndli F, M?nch G, Kuhla B, Rogaev EI, Tsolaki M, Papassotiropoulos A, G?tz J. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004 May 18; 101(20):7687-92.
Score: 0.011